Literature DB >> 15716796

Guidelines for nutritional support in intensive care unit patients: a critical analysis.

Jan Wernerman1.   

Abstract

PURPOSE OF REVIEW: Guidelines are supposed to be helpful in clinical practice. Guidelines are also supposed to rest upon the evidence that there is. In the field of clinical nutrition the problem is that many clinical trials are not conclusive because they are underpowered and sometimes have an inferior design. RECENT
FINDINGS: The publication of the Canadian guidelines one year ago initiated a lively debate. The Canadian guidelines used meta-analysis as a tool to review the literature. This resulted in both a sound evaluation of studies as well as some controversial recommendations. The Canadian guidelines are here put in a perspective in which the older type of guidelines are compared, and some of the points of recommendation are scrutinized.
SUMMARY: What all guidelines agree upon is the shortage of solid knowledge, the conviction that complications related to nutritional therapy in the intensive care unit are not acceptable, and that enteral nutrition is preferable if it can be given without risk. Beyond that, many controversies remain and the need for high quality prospective studies must be emphasized. In addition, such studies must address the clinically important questions that the guidelines try to answer.

Entities:  

Mesh:

Year:  2005        PMID: 15716796     DOI: 10.1097/00075197-200503000-00011

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  2 in total

1.  Metabolic changes after polytrauma: an imperative for early nutritional support.

Authors:  Erik Hasenboehler; Allison Williams; Iris Leinhase; Steven J Morgan; Wade R Smith; Ernest E Moore; Philip F Stahel
Journal:  World J Emerg Surg       Date:  2006-10-04       Impact factor: 5.469

2.  Preoperative hypoalbuminemia is associated with an increased risk for intra-abdominal septic complications after primary anastomosis for Crohn's disease.

Authors:  Xuanhui Liu; Xianrui Wu; Chi Zhou; Tuo Hu; Jia Ke; Yufeng Chen; Xiaosheng He; Xiaobin Zheng; Xiaowen He; Jiancong Hu; Min Zhi; Xiang Gao; Pinjin Hu; Xiaojian Wu; Ping Lan
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.